The anorectic stimulant aminorex was introduced in Europe in 1965, but soon withdrawn due to reports of resultant pulmonary hypertension. Excess thyroid hormone supplementation, widely used until ...
Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...